WVE - Wave Life Sciences Ltd logo

WVE

Wave Life Sciences Ltd

Wave Life Sciences Ltd develops RNA medicines using its PRISM platform, focusing on treatments for rare and common disorders. Key products include therapies for alpha-1 antitrypsin deficiency, obesity, liver disease, Duchenne muscular dystrophy, and Huntington's disease.

⚕️ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago $265today

Score Overview

1 Year
Score
Net Growth0.93%
Net TrendGrew
Net Income Consistency
Rev Growth53.00%
Rev TrendGrew
Revenue Consistency
5 Years
Score3.6
Net Growth-65.63%
Net Trend40%
Net Income Consistency
Rev Growth59.58%
Rev Trend40%
Revenue Consistency
10 Years
Score
Net Growth-265.47%
Net Trend40%
Net Income Consistency
Rev Growth44x
Rev Trend70%
Revenue Consistency
All Time
Score
Net Growth-8x
Net Trend36%
Net Income Consistency
Rev Growth430x
Rev Trend73%
Revenue Consistency

See the full market ranking →

Wave Life Sciences Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 20M to $ 42M and net income went from -$ 149M to -$ 204M. Revenue increased in 2 of those 5 years; net income in 2.

Across Wave Life Sciences Ltd's full reported history, from 2015 to 2025, revenue grew from $ 152K to $ 42M and net income went from -$ 19M to -$ 204M. Revenue increased in 73% of the years measured; net income in 36%.

Wave Life Sciences Ltd currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 5.24
1 Year2025-08-12
$ 8.45-37.99%
5 Years2021-08-12
$ 6.26-16.29%
10 Years2016-08-12
$ 19.76-73.48%
All Time2015-11-11
$ 16.00-67.25%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 65M-$ 202M$ 490M
2025$ 42M-$ 204M$ 602M
2024$ 108M-$ 97M$ 302M
2023$ 113M-$ 57M$ 200M
2022$ 3M-$ 161M$ 88M
2021$ 40M-$ 122M$ 150M
2020$ 20M-$ 149M$ 184M
2019$ 15M-$ 193M$ 147M
2018$ 14M-$ 146M$ 174M
2017$ 3M-$ 102M$ 142M
2016$ 1M-$ 55M$ 150M
IPO2015$ 152K-$ 19M$ 161M

Explore beyond WVE

You're looking at Wave Life Sciences Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies